4//SEC Filing
Duliege Anne-Marie 4
Accession 0001179110-18-005850
CIK 0001034842other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 9:06 PM ET
Size
4.8 KB
Accession
0001179110-18-005850
Insider Transaction Report
Form 4
Duliege Anne-Marie
Chief Medical Officer
Transactions
- Sale
Common Stock
2018-04-20$4.11/sh−5,000$20,550→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.
- [F2]The Reporting Person purchased these shares on December 29, 2017 under the Employee Stock Purchase Plan.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001419579
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 9:06 PM ET
- Size
- 4.8 KB